Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA
Takuji Suzuki, Takuro Sakagami, Bruce K Rubin, Lawrence M Nogee, Robert E Wood, Sarah L Zimmerman, Teresa Smolarek, Megan K Dishop, Susan E Wert, Jeffrey A Whitsett, Gregory Grabowski, Brenna C Carey, Carrie Stevens, Johannes C M van der Loo, Bruce C Trapnell, Takuji Suzuki, Takuro Sakagami, Bruce K Rubin, Lawrence M Nogee, Robert E Wood, Sarah L Zimmerman, Teresa Smolarek, Megan K Dishop, Susan E Wert, Jeffrey A Whitsett, Gregory Grabowski, Brenna C Carey, Carrie Stevens, Johannes C M van der Loo, Bruce C Trapnell
Abstract
Primary pulmonary alveolar proteinosis (PAP) is a rare syndrome characterized by accumulation of surfactant in the lungs that is presumed to be mediated by disruption of granulocyte/macrophage colony-stimulating factor (GM-CSF) signaling based on studies in genetically modified mice. The effects of GM-CSF are mediated by heterologous receptors composed of GM-CSF binding (GM-CSF-Ralpha) and nonbinding affinity-enhancing (GM-CSF-Rbeta) subunits. We describe PAP, failure to thrive, and increased GM-CSF levels in two sisters aged 6 and 8 yr with abnormalities of both GM-CSF-Ralpha-encoding alleles (CSF2RA). One was a 1.6-Mb deletion in the pseudoautosomal region of one maternal X chromosome encompassing CSF2RA. The other, a point mutation in the paternal X chromosome allele encoding a G174R substitution, altered an N-linked glycosylation site within the cytokine binding domain and glycosylation of GM-CSF-Ralpha, severely reducing GM-CSF binding, receptor signaling, and GM-CSF-dependent functions in primary myeloid cells. Transfection of cloned cDNAs faithfully reproduced the signaling defect at physiological GM-CSF concentrations. Interestingly, at high GM-CSF concentrations similar to those observed in the index patient, signaling was partially rescued, thereby providing a molecular explanation for the slow progression of disease in these children. These results establish that GM-CSF signaling is critical for surfactant homeostasis in humans and demonstrate that mutations in CSF2RA cause familial PAP.
Figures
References
- Trapnell, B.C., and J.A. Whitsett. 2002. GM-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu. Rev. Physiol. 64:775–802.
- Guthridge, M.A., J.A. Powell, E.F. Barry, F.C. Stomski, B.J. McClure, H. Ramshaw, F.A. Felquer, M. Dottore, D.T. Thomas, B. To, et al. 2006. Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch. EMBO J. 25:479–489.
- Shibuya, K., S. Chiba, K. Miyagawa, T. Kitamura, K. Miyazono, and F. Takaku. 1991. Structural and functional analyses of glycosylation on the distinct molecules of human GM-CSF receptors. Eur. J. Biochem. 198:659–666.
- Dranoff, G., A.D. Crawford, M. Sadelain, B. Ream, A. Rashid, R.T. Bronson, G.R. Dickersin, C.J. Bachurski, E.L. Mark, J.A. Whitsett, et al. 1994. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science. 264:713–716.
- Stanley, E., G.J. Lieschke, D. Grail, D. Metcalf, G. Hodgson, J.A. Gall, D.W. Maher, J. Cebon, V. Sinickas, and A.R. Dunn. 1994. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA. 91:5592–5596.
- Robb, L., C.C. Drinkwater, D. Metcalf, R. Li, F. Kontgen, N.A. Nicola, and C.G. Begley. 1995. Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc. Natl. Acad. Sci. USA. 92:9565–9569.
- Shibata, Y., P.Y. Berclaz, Z.C. Chroneos, M. Yoshida, J.A. Whitsett, and B.C. Trapnell. 2001. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity. 15:557–567.
- Ikegami, M., T. Ueda, W. Hull, J.A. Whitsett, R.C. Mulligan, G. Dranoff, and A.H. Jobe. 1996. Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation. Am. J. Physiol. 270:L650–L658.
- Seymour, J.F., and J.J. Presneill. 2002. Pulmonary alveolar proteinosis: progress in the first 44 years. Am. J. Respir. Crit. Care Med. 166:215–235.
- Trapnell, B.C., J.A. Whitsett, and K. Nakata. 2003. Pulmonary alveolar proteinosis. N. Engl. J. Med. 349:2527–2539.
- Presneill, J.J., K. Nakata, Y. Inoue, and J.F. Seymour. 2004. Pulmonary alveolar proteinosis. Clin. Chest Med. 25:593–613.
- Seymour, J.F., and J.J. Presneill. 2004. Pulmonary alveolar proteinosis. What is the role of GM-CSF in disease pathogenesis and treatment? Treat. Respir. Med. 3:229–234.
- Inoue, Y., B.C. Trapnell, R. Tazawa, T. Arai, T. Takada, N. Hizawa, Y. Kasahara, K. Tatsumi, M. Hojo, T. Ichiwata, et al. 2008. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am. J. Respir. Crit. Care Med. 177:752–762.
- Dirksen, U., R. Nishinakamura, P. Groneck, U. Hattenhorst, L. Nogee, R. Murray, and S. Burdach. 1997. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J. Clin. Invest. 100:2211–2217.
- Dirksen, U., U. Hattenhorst, P. Schneider, H. Schroten, U. Gobel, A. Bocking, K.M. Muller, R. Murray, and S. Burdach. 1998. Defective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure. Blood. 92:1097–1103.
- Bewig, B., X.D. Wang, D. Kirsten, K. Dalhoff, and H. Schafer. 2000. GM-CSF and GM-CSF beta c receptor in adult patients with pulmonary alveolar proteinosis. Eur. Respir. J. 15:350–357.
- Nogee, L.M., D.E. de Mello, L.P. Dehner, and H.R. Colten. 1993. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N. Engl. J. Med. 328:406–410.
- Nogee, L.M., A.E. Dunbar III, S.E. Wert, F. Askin, A. Hamvas, and J.A. Whitsett. 2001. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N. Engl. J. Med. 344:573–579.
- Shulenin, S., L.M. Nogee, T. Annilo, S.E. Wert, J.A. Whitsett, and M. Dean. 2004. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N. Engl. J. Med. 350:1296–1303.
- Whitsett, J.A., S.E. Wert, and B.C. Trapnell. 2004. Genetic disorders influencing lung formation and function at birth. Hum. Mol. Genet. 13:R207–R215.
- Uchida, K., K. Nakata, B.C. Trapnell, T. Terakawa, E. Hamano, A. Mikami, I. Matsushita, J.F. Seymour, M. Oh-Eda, I. Ishige, et al. 2004. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood. 103:1089–1098.
- Iyonaga, K., M. Suga, T. Yamamoto, H. Ichiyasu, H. Miyakawa, and M. Ando. 1999. Elevated bronchoalveolar concentrations of MCP-1 in patients with pulmonary alveolar proteinosis. Eur. Respir. J. 14:383–389.
- Paine, R. III, S.B. Morris, H. Jin, S.E. Wilcoxen, S.M. Phare, B.B. Moore, M.J. Coffey, and G.B. Toews. 2001. Impaired functional activity of alveolar macrophages from GM-CSF-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:L1210–L1218.
- Uchida, K., D.C. Beck, T. Yamamoto, P.Y. Berclaz, S. Abe, M.K. Staudt, B.C. Carey, M.D. Filippi, S.E. Wert, L.A. Denson, et al. 2007. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N. Engl. J. Med. 356:567–579.
- Seymour, J.F., I.R. Doyle, K. Nakata, J.J. Presneill, O.D. Schoch, E. Hamano, K. Uchida, R. Fisher, and A.R. Dunn. 2003. Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis. Thorax. 58:252–257.
- Rennard, S.I., G. Basset, D. Lecossier, K.M. O'Donnell, P. Pinkston, P.G. Martin, and R.G. Crystal. 1986. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 60:532–538.
- Ding, D.X., J.C. Vera, M.L. Heaney, and D.W. Golde. 1995. N-glycosylation of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit is essential for ligand binding and signal transduction. J. Biol. Chem. 270:24580–24584.
- Shears, D.J., H.J. Vassal, F.R. Goodman, R.W. Palmer, W. Reardon, A. Superti-Furga, P.J. Scambler, and R.M. Winter. 1998. Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis. Nat. Genet. 19:70–73.
- Kitamura, T., K. Uchida, N. Tanaka, T. Tsuchiya, J. Watanabe, Y. Yamada, K. Hanaoka, J.F. Seymour, O.D. Schoch, I. Doyle, et al. 2000. Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am. J. Respir. Crit. Care Med. 162:658–662.
- Kitamura, T., N. Tanaka, J. Watanabe, K. Uchida, S. Kanegasaki, Y. Yamada, and K. Nakata. 1999. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 190:875–880.
- Nogee, L.M. 2004. Alterations in SP-B and SP-C expression in neonatal lung disease. Annu. Rev. Physiol. 66:601–623.
- Redon, R., S. Ishikawa, K.R. Fitch, L. Feuk, G.H. Perry, T.D. Andrews, H. Fiegler, M.H. Shapero, A.R. Carson, W. Chen, et al. 2006. Global variation in copy number in the human genome. Nature. 444:444–454.
Source: PubMed